Virtual slide telepathology enables an innovative telehealth rapid breast care clinic

Human Pathology

Volumn 40, Issue 8, 2009, Pages 1082-1091

  López, Ana Maria ^a,b   Graham, Anna R ^a,b   Barker, Gail P ^a,b,c,d   Richter, Lynne C ^a   Krupinski, Elizabeth A ^a,b   Lian, Fangru ^a,b   Grasso, Lauren L ^a,b   Miller, Ashley ^c   Kreykes, Lindsay N ^c   Henderson, Jeffrey T ^a   Bhattacharyya, Achyut K ^a   Weinstein, Ronald S ^a,b,d  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d T Health Institute   (United States)

Author keywords

Breast cancer; Cancer; Digital pathology; HER 2 neu; Immunohistochemistry; Mammography; Quality assurance; Telehealth; Telemedicine; Telepathology; Virtual microscopy; Virtual slides

Indexed keywords

ACTIN; CALPONIN; CYTOKERATIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ARTICLE; BREAST CANCER; BREAST HYPERPLASIA; DEVICE; IMMUNOHISTOCHEMISTRY; JOB SATISFACTION; LABORATORY; MAMMOGRAPHY; PATHOLOGIST; PRODUCTIVITY; QUALITY CONTROL; TELECONSULTATION; TELEHEALTH; TELEONCOLOGY; TELEPATHOLOGY; TELERADIOLOGY; UNITED STATES; UNIVERSITY HOSPITAL; VALIDATION STUDY; VIRTUAL MICROSCOPY; VIRTUAL SLIDE TELEPATHOLOGY;

BREAST NEOPLASMS; DIAGNOSTIC ERRORS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MAMMOGRAPHY; MASS SCREENING; MEDICAL INFORMATICS APPLICATIONS; MEDICAL ONCOLOGY; MICROSCOPY; PATHOLOGY, SURGICAL; QUALITY ASSURANCE, HEALTH CARE; TELEPATHOLOGY; TUMOR MARKERS, BIOLOGICAL;

EID: 67650434424     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2009.04.005     Document Type: Article

References (46)

1. Urban J.A. Breast cancer. What have we learned. Cancer 57 (1986) 636-643
2. Imaginis B. The Breast Health Resource. Breast biopsy: indications and methods (2005). http://imaginis.com/breasthealth/biopsy/#introduction
3. Susan G. Komen Breast Cancer Foundation. About breast cancer: diagnosis and types of biopsies (2005). www.komen.org/
4. Blanchet K. Innovative programs in telemedicine. The Arizona Telemedicine Program. Telemedicine & e-Health 11 (2005) 633-640
5. Weinstein R.S., Barker G.P., Beinar S., et al. Policy and the Origins of the Arizona Statewide Telemedicine Program. In: Whitten P., and Cook D. (Eds). Understanding health communications technologies (2004), Jossey-Bass, San Francisco 299-309
6. www.telemedicine.arizona.edu (accessed August 17, 2006).
7. Barker G.P., Krupinski E.A., McNeely R.A., Holcomb M.J., Lopez A.M., and Weinstein R.S. The Arizona Telemedicine Program Business Model. J Telemed Telecare 11 (2005) 397-402
8. Weinstein R.S., Lopez A.M., Barker G.P., et al. The innovative bundling of teleradiology, telepathology and teleoncology services. IBM Systems J 46 (2007) 69-84
9. Weinstein R.S., Bhattacharyya A.K., Graham A.R., and Davis J.R. Telepathology: a ten-year progress report. Hum Pathol 28 (1997) 1-7
10. Weinstein R.S., Descour M.R., Liang C., et al. Telepathology overview. From concept to implementation. Hum Pathol 32 (2001) 1283-1299
11. Kayser K., Szymas J., and Weinstein R.S. Telepathology and telemedicine: communication. Electronic education and publication in e-health (2005), VSV Interdisciplinary Medical Publishing, Berlin 1-257
12. Weinstein R.S., Bloom K.J., and Rozek L.S. Telepathology and the networking of pathology diagnostic services. Arch Path Lab Med 111 (1987) 646-652
13. Wysocki W.M., Komorowski A.L., and Aapro M.S. The new dimension of oncology: teleoncology ante portas. Crit Rev Oncol Hematol 53 (2005) 95-100
14. Allen A., and Hayes J. Patient satisfaction with teleoncology: a pilot study. Telemed J 1 (1995) 41-46
15. Doolittle G.C., and Allen A. Practicing oncology via telemedicine. J Telemed Telecare 3 (1997) 63-70
16. Maheu M.M., Whitten P., and Allen A. E-health, telehealth and telemedicine. a guide to start-up and success (2001), Jossey-Bass, San Francisco 1-380
17. Darkins A.W., and Cary M.A. Telemedicine and telehealth. Principles, policies, performance and pitfalls (2000), Springer, Publishing Company, New York 1-316
18. Lopez A.M., Venker C., Howerter A., et al. Demonstration of an expedited breast care (EBC) clinic. (abstract). J Clin Oncol 24 (2006) 661
19. Wolff A.C., Hammond M.E., Schwartz J.N., et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med 131 (2007) 18-43
20. Barrett C., Brett F., Grehan D., and McDermott M.B. Heat-accelerated fixation and rapid dissection of the pediatric brain at autopsy: a pragmatic approach to the difficulties of organ retention. Ped Devel Pathol 7 (2004) 595-600
21. Emerson L.L., Tripp S.R., Baird B.C., Layfield L.J., and Rohr L.R. A comparison of immunohistochemical stain quality in conventional and rapid microwave processed tissues. Anat Pathol 125 (2006) 176-183
22. Schroeder J.A., Gelderblom H.R., Hauroeder B., Schmetz C., Milios J., and Hofstaedter F. Microwave-assisted tissue processing for same-day EM-diagnosis of potential bioterrorism and clinical samples. Micron (2005) 577-590
23. Graham A.R., Bhattacharyya A.K., Scott K.M., et al. Virtual slide telepathology for an anatomic surgical pathology quality assurance program. Hum Pathol 40 (2009) 1129-1136
24. Dean-Colomb W., and Esteva F.J. Her2-positive breast cancer: herceptin and beyond. Eur J Cancer 44 (2008) 2806-2812
25. Ellis M.J., Tao Y., Luo J., et al. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics. JNCI 100 (2008) 1380-1388
26. Romond E.H., Perez E.A., Bryant J., Suman V.J., et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 353 (2005) 1673-1684
27. Allred D.C. Commentary: hormone receptor testing in breast cancer: a distress signal from Canada. Oncologist 13 (2008) 1134-1136
28. Hede K. Breast cancer testing scandal shines spotlight on black box of clinical laboratory testing. J Natl Cancer Inst 2008;100(12):836-37, 844.
29. Gown A.M., Goldstein L.C., Barry T.S., et al. High concordance between immunohistochemistry and fluorescence in situ hybridization testing for HER2 status in breast cancer requires a normalized IHC scoring system. Mod Pathol 21 (2008) 1271-1277
30. Weinstein R.S., Descour M.R., Liang C., et al. An array microscope for ultrarapid virtual slide processing and telepathology. Design, fabrication, and validation study. Hum Pathol 35 (2004) 1303-1314
31. Weinstein R.S., Descour M.R., Liang C., et al. Reinvention of light microscopy. array microscopy and ultrarapidly scanned virtual slides for diagnostic pathology and medical education. In: Gu J., and Oglivie R.W. (Eds). Virtual microscopy and virtual slides in teaching, diagnosis and research (2005), CRC Press 9-35
32. Putchtler H., and Meloan S.N. On the chemistry of formaldehyde fixation and its effects on immunohistochemical reactions. Histochem Cell Biol 82 (1985) 201-204
33. Taylor C.R. Immunomicroscopy: a diagnostic tool for the surgical pathologist (1986), Saunder WB, Phila (Pa)
34. Shi S.R., Key M.E., and Kalra K.L. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39 (1991) 741-748
35. Shi S.R., et al. Antigen retrieval technique: a novel approach to imunohistochemistry on routinely processed tissue sections. In: Gu J. (Ed). Analytical Morphology: Theory, Library and Protocols (1996), Eaton Publishing
36. Rait V.K., O'Leary T.J., and Mason J.T. Modeling formalin fixation and antigen retrieval with bovine pancreatic ribonuclease A: I-structural and functional alteration. Lab Invest 84 (2004) 292-299
37. Sompuram S.R., Vani K., Messana E., and Bogen S.A. A molecular mechanism of formalin fixation and antigen retrieval. Am J Clin Pathol 21 (2004) 190-199
38. Gown A.M. Current issues in ER and HER2 testing by IHC in breast cancer. Mod Pathol 21 (2008) S8-S15
39. Ragazzini T., Magrini E., Cucchi M.C., Foschini M.P., and Eusebi V. The fast-track biopsy (FTB): description of a rapid histology and immunohistochemistry method for evaluation of preoperative breast core biopsies. Int J Surg Pathol 13 (2005) 247-252
40. Lang E.V., and Berbaum K.S. Lutgenforg S.K. Large-core breast biopsy: abnormal salivary cortisol profiles associated with uncertainty of diagnosis. Radiology 250 (2009) 631-637
41. Gustafsson O., Theorell T., Norming U., Perski A., Obstrom M., and Nyman C.R. Psychological reactions in men screened for prostate cancer. Br J Urol 75 (1995) 631-636
42. Aardal-Eriksson E., Eirksson T.E., and Thorell L.H. Salivary cortisol, post traumatic stress symptoms, and general health in the acute phase and during 9 month follow-up. Biol Psychiatry 50 (2001) 986-993
43. Glaser R., Kiecoh-Glaser J.K., Marucha P.T., MacCallium R.C., Laskowski D.F., and Malarkey W.B. Stress-related changes in proinflammatory cytokine production in wounds. Arch Gen Psychiatry 56 (1999) 450-456
44. Webster M.J.I., and Glaser R. Stress hormones and immune function. Cell Immunol 252 (2008) 16-26
45. Abercrombie H.C., Giese-Davis J., Sephton S., Epel E.S., Turner-Cobb J.M., and Spiegel D. Flattened cortisol rhythms in metastatic breast cancer patients. Psychoneuroendocrinology 29 (2004) 1082-1092
46. Heys S.D., Sarkar T., and Hutcheon A.W. Primary docetaxel chemotherapy in patients with breast cancer: impact on response and survival. Breast Cancer Res Treat 90 (2005) 169-185